Patent · US Active

Genetically modified non-human animal with human or chimeric TIM-3

US11240995B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Jian Ni · Rockville, US
Yanan Guo · Beijing, CN
Rui Huang · Beijing, CN
Meiling Zhang · Beijing, CN
Lei Zhao · Addison, US
Yang Bai · Beijing, CN

Key dates

Filing date	May 10, 2019
Grant date	Feb 8, 2022
Priority date	—
Expiry date	May 10, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/20
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present disclosure relates to the genetically modified non-human animals that express a human or chimeric (e.g., humanized) T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.